Detalles de la búsqueda
1.
Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer.
Intern Med;
2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749728
2.
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060.
JTO Clin Res Rep;
5(4): 100655, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706978
3.
Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab.
Cancers (Basel);
16(7)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38611087
4.
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
Oncology;
102(1): 30-42, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598676
5.
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study).
Thorac Cancer;
15(2): 163-171, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38013668
6.
Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report.
Case Rep Oncol;
16(1): 1345-1352, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946746
7.
Analysis of source dwell position during treatment in brachytherapy using CT scout images.
J Contemp Brachytherapy;
15(5): 357-364, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38026071
8.
Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report.
Thorac Cancer;
14(31): 3161-3165, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699791
9.
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Thorac Cancer;
14(25): 2567-2578, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37469246
10.
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial.
Cancer Sci;
114(8): 3342-3351, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139543
11.
Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensivedisease small cell lung cancer.
Oncol Lett;
25(3): 111, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36817046
12.
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer.
Cancer Med;
12(1): 73-83, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699088
13.
[Biological Effects of Low Dose and Low Dose Rate Radiation].
Nihon Hoshasen Gijutsu Gakkai Zasshi;
78(11): 1376-1380, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-36403971
14.
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.
Thorac Cancer;
13(19): 2776-2785, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36062426
15.
Herpes zoster in patients with lung cancer treated with PD-1/PD-L1 antibodies.
Immunotherapy;
14(15): 1211-1217, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039980
16.
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Invest New Drugs;
40(5): 1066-1079, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749041
17.
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
Front Oncol;
12: 1080729, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36741711
18.
Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer.
Cancer Med;
10(23): 8595-8603, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617674
19.
Dramatic response to alectinib in a patient with ALK-rearranged squamous cell lung cancer.
Thorac Cancer;
12(17): 2420-2423, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324792
20.
Pulmonary mucoepidermoid carcinoma arising in a patient with Kartagener syndrome.
BMC Pulm Med;
20(1): 93, 2020 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32299405